Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
100
days
Development of Integrated Parent–Metabolite Pharmacokinetic Model With Apparent Presystemic Metabolism to Characterize the Disposition of Alverine
AuthorsAra Cho; Hyeon‐Cheol Jeong; MinJu Kim; Inkyung Cho; Hyeon‐Jeong Na; Kyong‐Cheol Ko; Yoon‐Jee Chae; Kyeong‐Ryoon Lee
Affiliations1. Advanced Alternative Testing Team Korea Research Institute of Bioscience and Biotechnology Cheongju Republic of Korea; 2. Korea Preclinical Evaluation Center Korea Research Institute of Bioscience and Biotechnology Daejeon Republic of Korea; 3. Laboratory Animal Resource & Research Center Korea Research Institute of Bioscience and Biotechnology Cheongju Republic of Korea; 4. Department of Pharmacology, College of Medicine Konyang University Daejeon Republic of Korea; 5. Department of Bioengineering University of Science and Technology Daejeon Republic of Korea
172
days
Integrating CRRT as a Virtual Organ Into Physiologically Based Pharmacokinetic Modeling to Optimize Antimicrobial Dosing in Septic Patients
AuthorsYuanming Xing; Yijing Zhang; Chuqi Bai; Yulan Qiu; Chuhui Wang; Lei Chen; Taotao Wang; Jiaojiao Chen
Affiliations1. Department of Cardiovascular Medicine The First Affiliated Hospital of Xi'an Jiaotong University Xi'an China; 2. Department of Pharmacy The First Affiliated Hospital of Xi'an Jiaotong University Xi'an China; 3. Department of Hemodialysis The First Affiliated Hospital of Xi'an Jiaotong University Xi'an China
163
days
Net Renal Drug Secretion Critically Requires Significant Contribution of Basal Uptake Transporters: Perspective From Mechanistic Kidney Model Simulation and Integration of Clinical and In Vitro Data
AuthorsToshiaki Tsuchitani; Masatoshi Tomi; Yuichi Sugiyama
Affiliations1. Faculty of Pharmacy Keio University Tokyo Japan; 2. Genomembrane Co. Ltd Yokohama Kanagawa Japan; 3. iHuman Institute ShanghaiTech University Shanghai China
120
days
Model‐Based Tacrolimus Dosing Using the Population Pharmacokinetic Analysis Under the Nirmatrelvir/Ritonavir Therapy
AuthorsKotaro Itohara; Yoshiki Katada; Takahiro Hatayama; Toshiaki Igarashi; Jiro Ogura; Tomoki Fukushima; Shingo Yamazaki; Masato Homma; Takashi Niwa; Yoshiaki Kato; Nanae Yamamoto; Hideyuki Terazono; Hideo Shiohira; Tomohiro Terada; Ikuko Yano
Affiliations1. Department of Pharmacy Kobe University Hospital Kobe Japan; 2. Department of Clinical Pharmacology and Therapeutics Kyoto University Hospital Kyoto Japan; 3. Department of Pharmacy Hirosaki University Hospital Hirosaki Japan; 4. Department of Pharmaceutical Sciences Tohoku University Hospital Sendai Japan; 5. Department of Pharmacy Yamagata University Hospital Yamagata Japan; 6. Department of Pharmacy University of Yamanashi Hospital Chuo Japan; 7. Division of Pharmacy Chiba University Hospital Chiba Japan; 8. Department of Pharmacy University of Tsukuba Hospital Tsukuba Japan; 9. Department of Pharmacy Gifu University Hospital Gifu Japan; 10. Department of Hospital Pharmacy Nagoya University Hospital Nagoya Japan; 11. Department of Pharmacy Kyushu University Hospital Fukuoka Japan; 12. Department of Pharmacy Kagoshima University Hospital Kagoshima Japan; 13. Department of Pharmacy University of the Ryukyus Hospital Ginowan Japan; 14. Laboratory of Clinical Pharmacy Showa Pharmaceutical University Machida Japan
100
days
Semi‐Mechanistic Modeling of S‐531011, a Humanized Anti‐ CCR8 Monoclonal Antibody, for Prediction of CCR8 Receptor Occupancy in Human Tumor Tissues
AuthorsDaichi Yamaguchi; Wataru Nogami; Yudai Sonoda; Hitomi Morihara; Takayuki Katsube
Affiliations1. Clinical Pharmacology and Pharmacokinetics Shionogi and Co., Ltd. Osaka Japan; 2. Laboratory for Drug Discovery and Development Shionogi and Co., Ltd. Osaka Japan
111
days
Pharmaceutical Industry Perspectives on Exposure‐Response Confounding in Large Molecule Therapeutics: Results From an IQ Consortium Survey
AuthorsEngie Salama; Manisha Lamba; Sihem Ait‐Oudhia; Ellen Wang; Dorothee Semiond; Zhang Li; Tao Long; Satyendra Suryawanshi; Leticia Arrington; Wei Gao; Xiaowen Guan; Hugh Giovinazzo; Dale Miles; David C. Turner
Affiliations1. Clinical Pharmacology & Pharmacometrics Xencor Pasadena California USA; 2. Pharmacometrics & Systems Pharmacology Pfizer Pearl River New York USA; 3. Quantitative Pharmacology and Pharmacometrics Merck & Co, Inc. Rahway New Jersey USA; 4. Translational Clinical Sciences, Internal Medicine Clinical Pharmacology Pfizer New York New York USA; 5. Sanofi R&D Cambridge Massachusetts USA; 6. Quantitative Clinical Pharmacology Daiichi Sankyo Basking Ridge New Jersey USA; 7. Takeda Development Center Americas, Inc. (TDCA) Cambridge Massachusetts USA; 8. Bristol Myers Squibb Princeton New Jersey USA; 9. Amgen Inc. Thousand Oaks California USA; 10. Moderna Therapeutics, Inc. Cambridge Massachusetts USA; 11. Regeneron Pharmaceuticals Tarrytown New York USA; 12. BeOne Medicines, Ltd San Carlos California USA; 13. Clinical Pharmacology Genentech South San Francisco California USA
175
days
Precision Dosing of Tacrolimus in Liver Transplantation: Integrating Donor‐Recipient CYP3A5 Pharmacogenomics and Drug Interactions
AuthorsVirunya Komenkul; Prawat Chantharit; Piyawat Komolmit; Bunthoon Nonthasoot; Athaya Vorasittha; Anapat Sanpavat; Sirinporn Suksawatamnuay; Chandramouli Radhakrishnan; Thitima Wattanavijitkul
Affiliations1. Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences Chulalongkorn University Bangkok Thailand; 2. Department of Pharmaceutical Care, Faculty of Pharmacy Silpakorn University Nakorn Pathom Thailand; 3. Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University Bangkok Thailand; 4. Excellence Center in Liver Diseases King Chulalongkorn Memorial Hospital, Thai Red Cross Society Bangkok Thailand; 5. Department of Surgery, Faculty of Medicine Chulalongkorn University & King Chulalongkorn Memorial Hospital Bangkok Thailand; 6. Department of Pathology, Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Bangkok Thailand; 7. Certara Radnor Pennsylvania USA
129
days
Adjoint and Unrolled Automatic Differentiation for Laplace‐Approximated Likelihoods in Population PK and PK / PD Models
AuthorsGuido H. Jajamovich; William Holmes; Chih‐Wei Lin; Khamir Mehta
Affiliations1. Clinical Pharmacology Modeling and Simulation Amgen South San Francisco California USA; 2. Clinical Pharmacology Modeling and Simulation Amgen Thousand Oaks California USA
106
days
Transporter‐Drive Interstitial Tissue Exposure and Pharmacodynamic Response of Meropenem in Sepsis: A Mechanistic PBPK Modeling Study
AuthorsLaura Ben Olivo; Jessica Luisa Silva de Lemos; Vinicius Jardim Rodrigues; Bibiana Verlindo de Araújo
Affiliations1. Pharmaceutical Sciences Graduate Program Federal University of Rio Grande Do Sul Porto Alegre Brazil; 2. Biological Sciences Graduate Program: Pharmacology and Therapeutics Federal University of Rio Grande Do Sul Porto Alegre Brazil
135
days
Deciphering the Mechanisms of Statin–Ezetimibe Drug Combinations Using Boolean Logical Modeling and Transcriptomic Data
AuthorsRui‐Sheng Wang; Matteo Pedrelli; Osman Ahmed; Garagnani Paolo; Paolo Parini; Joseph Loscalzo
Affiliations1. Department of Medicine Brigham and Women's Hospital Boston USA; 2. Cardio Metabolic Unit, Department of Medicine and Department of Laboratory Medicine Karolinska Institute Huddinge Sweden; 3. Medical Unit Endocrinology, Theme Inflammation and Ageing Karolinska University Hospital Stockholm Sweden; 4. Department of Biochemistry, College of Medicine and Health Sciences Arabian Gulf University Manama Kingdom of Bahrain; 5. Department of Experimental, Diagnostic and Specialty Medicine (DIMES) University of Bologna Bologna Italy
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days